Synthibase - 2026 Pricing, Features, Reviews & Alternatives

Synthibase is a synthetic test data generation platform designed for healthcare IT implementation teams conducting EDI and HL Seven go-live testing. The software addresses a critical bottleneck in healthcare system implementations by generating synthetic X Twelve and HL Seven transactions from a persistent patient registry and eliminating the need for protected health information in test environments. The platform serves integrated delivery networks, hospitals and healthcare IT departments that work with electronic health record systems such as Epic, Cerner, Meditech and Allscripts, as well as clearinghouse platforms including Edifecs and Rhapsody. Implementation directors, EDI and HL Seven analysts and IT leadership use the platform to maintain HIPAA compliance while accelerating go-live activities.

The platform generates clinically coherent synthetic patient cohorts configured to match an organization’s specific payer mix and enables valid test data production within a single day instead of a three-week timeline associated with traditional fixture building. Synthibase supports comprehensive X Twelve transaction sets including eight three seven P for professional claims, eight three seven I for institutional claims, eight three seven D for dental claims, eight three five for remittance advice, eight three four for enrollment, two seven seven for claim status, two seven seven A for claim acknowledgment and two seven eight for authorization as well as HL Seven version two ADT messages. Built-in support for coordination of benefits, retroactive authorizations, claim denials and split billing configurations ensures coverage of complex billing scenarios. The persistent patient registry maintains referential integrity across all generated transactions by linking members, providers and payers in a clinically coherent manner. Browser-local de-identification processes ensure that no protected health information is ever ingested, stored or transmitted through the system. Synthetic patient cohorts are reusable across multiple projects, allowing implementation teams to start subsequent go-lives from an advanced baseline rather than rebuilding test fixtures from scratch.

Synthibase functions as a cloud-based software as a service platform with HIPAA-aligned architecture and offers Business Associate Agreement availability for covered entities requiring formal compliance documentation. The platform integrates into existing healthcare IT testing workflows without requiring connections to production systems or access to live patient data. Although specific third-party integration details are not extensively documented in the available information, support for major electronic health record systems and clearinghouse platforms suggests compatibility with standard healthcare interoperability protocols and transaction formats. The software enables teams to generate their first synthetic eight three seven transaction within ten minutes of initial signup and full payer-configured cohorts are typically ready within one day of platform configuration.

These capabilities support go-live testing activities and reduce the compliance risks associated with using real patient data in testing environments.